ZA905978B - Derivatives of 1,2,3,4-tetrahydro-9-acridinamine - Google Patents
Derivatives of 1,2,3,4-tetrahydro-9-acridinamineInfo
- Publication number
- ZA905978B ZA905978B ZA905978A ZA905978A ZA905978B ZA 905978 B ZA905978 B ZA 905978B ZA 905978 A ZA905978 A ZA 905978A ZA 905978 A ZA905978 A ZA 905978A ZA 905978 B ZA905978 B ZA 905978B
- Authority
- ZA
- South Africa
- Prior art keywords
- acridinamine
- tetrahydro
- derivatives
- agents
- cerebral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/387,722 US4999430A (en) | 1989-07-31 | 1989-07-31 | Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA905978B true ZA905978B (en) | 1992-04-29 |
Family
ID=23531113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA905978A ZA905978B (en) | 1989-07-31 | 1990-07-30 | Derivatives of 1,2,3,4-tetrahydro-9-acridinamine |
Country Status (17)
Country | Link |
---|---|
US (1) | US4999430A (ko) |
EP (2) | EP0628548B1 (ko) |
JP (1) | JP2930245B2 (ko) |
KR (1) | KR910002802A (ko) |
AT (2) | ATE186908T1 (ko) |
AU (1) | AU5994590A (ko) |
CA (1) | CA2022297C (ko) |
DE (2) | DE69033369T2 (ko) |
DK (2) | DK0628548T3 (ko) |
ES (2) | ES2068955T3 (ko) |
FI (1) | FI903752A0 (ko) |
GR (1) | GR3032539T3 (ko) |
IE (1) | IE66823B1 (ko) |
NO (1) | NO903359L (ko) |
NZ (1) | NZ234672A (ko) |
PT (1) | PT94849A (ko) |
ZA (1) | ZA905978B (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI91401C (fi) * | 1987-03-17 | 1994-06-27 | Hoechst Roussel Pharma | Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi |
FR2640508B1 (fr) * | 1988-12-19 | 1994-07-01 | Dietlin Francois | Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire |
JP2546919B2 (ja) * | 1989-11-08 | 1996-10-23 | 三菱化学株式会社 | 9ーアシルアミノテトラヒドロアクリジン誘導体 |
CA2029497C (en) * | 1989-11-08 | 2002-06-04 | Kunihiro Ninomiya (Deceased) | 4-acylaminopyridine derivative |
US5179100A (en) * | 1992-03-09 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Inc. | 4,5-dihydropyrazolo[3,4-a]acridines |
US5422350A (en) * | 1992-09-10 | 1995-06-06 | Warner-Lambert Company | Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
HU213107B (en) * | 1994-02-23 | 1997-02-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing acetic acid derivatives and pharmaceutical compositions containing them |
GB9716879D0 (en) * | 1997-08-08 | 1997-10-15 | Shire Int Licensing Bv | Treatment of attention deficit disorders |
US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
ES2168926B1 (es) * | 1999-12-14 | 2003-10-16 | Prous Science S A | Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente. |
WO2006004201A1 (ja) * | 2004-07-01 | 2006-01-12 | Eisai R & D Management Co., Ltd. | 神経再生促進剤 |
CN1315810C (zh) * | 2004-08-30 | 2007-05-16 | 北京理工大学 | 哌嗪桥联他克林双体衍生物及其合成方法 |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
WO2011070177A2 (en) * | 2009-12-11 | 2011-06-16 | Baltic Technology Development, Ltd. | Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators |
EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985430A (en) * | 1987-12-03 | 1991-01-15 | Mitsubishi Kasei Corporation | 9-acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient |
-
1989
- 1989-07-31 US US07/387,722 patent/US4999430A/en not_active Expired - Lifetime
-
1990
- 1990-07-27 NZ NZ234672A patent/NZ234672A/xx unknown
- 1990-07-27 FI FI903752A patent/FI903752A0/fi not_active Application Discontinuation
- 1990-07-27 AU AU59945/90A patent/AU5994590A/en not_active Abandoned
- 1990-07-30 ZA ZA905978A patent/ZA905978B/xx unknown
- 1990-07-30 NO NO90903359A patent/NO903359L/no unknown
- 1990-07-30 CA CA002022297A patent/CA2022297C/en not_active Expired - Fee Related
- 1990-07-30 IE IE275190A patent/IE66823B1/en not_active IP Right Cessation
- 1990-07-30 PT PT94849A patent/PT94849A/pt not_active Application Discontinuation
- 1990-07-30 ES ES90114586T patent/ES2068955T3/es not_active Expired - Lifetime
- 1990-07-30 DK DK94112223T patent/DK0628548T3/da active
- 1990-07-30 JP JP2199361A patent/JP2930245B2/ja not_active Expired - Fee Related
- 1990-07-30 AT AT94112223T patent/ATE186908T1/de not_active IP Right Cessation
- 1990-07-30 EP EP94112223A patent/EP0628548B1/en not_active Expired - Lifetime
- 1990-07-30 DK DK90114586.2T patent/DK0411534T3/da active
- 1990-07-30 DE DE69033369T patent/DE69033369T2/de not_active Expired - Fee Related
- 1990-07-30 EP EP90114586A patent/EP0411534B1/en not_active Expired - Lifetime
- 1990-07-30 KR KR1019900011578A patent/KR910002802A/ko not_active Application Discontinuation
- 1990-07-30 ES ES94112223T patent/ES2141787T3/es not_active Expired - Lifetime
- 1990-07-30 DE DE69017789T patent/DE69017789T2/de not_active Expired - Fee Related
- 1990-07-30 AT AT90114586T patent/ATE119885T1/de not_active IP Right Cessation
-
2000
- 2000-02-02 GR GR20000400235T patent/GR3032539T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0411534A3 (en) | 1991-06-05 |
DE69017789D1 (de) | 1995-04-20 |
ATE186908T1 (de) | 1999-12-15 |
CA2022297A1 (en) | 1991-02-01 |
US4999430A (en) | 1991-03-12 |
NZ234672A (en) | 1991-11-26 |
KR910002802A (ko) | 1991-02-26 |
ATE119885T1 (de) | 1995-04-15 |
NO903359L (no) | 1991-02-01 |
DE69033369D1 (de) | 1999-12-30 |
DK0628548T3 (da) | 2000-05-08 |
IE902751A1 (en) | 1991-02-27 |
DE69033369T2 (de) | 2000-05-11 |
AU5994590A (en) | 1991-01-31 |
EP0628548A1 (en) | 1994-12-14 |
GR3032539T3 (en) | 2000-05-31 |
ES2068955T3 (es) | 1995-05-01 |
IE66823B1 (en) | 1996-02-07 |
CA2022297C (en) | 2001-09-18 |
JPH0366670A (ja) | 1991-03-22 |
ES2141787T3 (es) | 2000-04-01 |
FI903752A0 (fi) | 1990-07-27 |
EP0411534B1 (en) | 1995-03-15 |
DK0411534T3 (da) | 1995-07-24 |
JP2930245B2 (ja) | 1999-08-03 |
EP0628548B1 (en) | 1999-11-24 |
PT94849A (pt) | 1991-04-18 |
EP0411534A2 (en) | 1991-02-06 |
NO903359D0 (no) | 1990-07-30 |
DE69017789T2 (de) | 1995-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0411534A3 (en) | Derivatives of 1,2,3,4-tetrahydro-9-acridinamine | |
IT1229203B (it) | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. | |
ZA906057B (en) | 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents | |
NZ232207A (en) | Dihydrobenz(c)acridine derivatives and pharmaceutical compositions | |
ES2009689A6 (es) | Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima. | |
AU5992990A (en) | 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents | |
ZA891769B (en) | Heterocyclic compounds | |
AU653802B2 (en) | Condensed diazepinones | |
CS53688A2 (en) | Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production | |
ES2008421A6 (es) | Procedimiento para la obtencion de derivados de la pilocarpina. | |
DK0950053T3 (da) | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater | |
HU904619D0 (en) | Process for the production of medicative preparation for treating phlebitis | |
GB9301354D0 (en) | Process for the production of flavonic compounds combined or otherwise by in vitro culture of ginkgo biloba tissues |